The stock of Berkeley Lights Inc (BLI) closed the recent trading session at $6.31, gaining 6.41% from the previous day’s trading session. On the last check, BLI stock remained bullish in the after-market and further gained 1.74% to $6.42. The company declared to appoint a new CEO. The firm also filed form 8-K with the SEC to declare the new CEO of the company.
News
On 9 March 2022, BLI declared to appoint Dr. Siddhartha Kadia as the new CEO. Dr. Siddhartha Kadia will take over the place of Eric D. Hobbs and will also play his part as a BoD. He also filled in as a head and CEO of EAG Laboratories. Before EAG Labs, Dr. Kadia worked in a few high-ranking leadership positions as well as the head at the Life Technologies Corporation.
Dr. Siddhartha commented that he is regarded to guide the skilled Berkeley Lights group. He further added that he anticipates utilizing his wisdom in driving life sciences and administrations businesses as they expand the firm’s force. Dr. Kadia concluded that he is sure that together they can open the gigantic possibilities to convey significant incentives for both clients and investors.
The company also declared that the CFO of BLI will be giving up his duties and will serve as a CFO till 1 April 2022. Kurt Wood, the CFO of Berkeley lights will serve as an advisor till 30 April 2022, to help with the new nomination.
Moreover, on 4 March 2022, BLI declared its participation in the Biologics meeting. The festival unites pharma, biotech, and scholastic. It also unites accomplices in the space of antibodies, immunotherapy, and biosimilars.
About BLI
Berkeley Lights Inc takes part in the development of biotherapeutics and other cell-based products. The organization is engaged to empower and speed up the development of biotherapeutics and other cell-based items. BLI has its headquarter in Emeryville, California, USA.